thiophenes has been researched along with navitoclax in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lartigue, L; Perkins, G; Yamaguchi, R | 1 |
Arulananda, S; Behren, A; Cebon, J; Dobrovic, A; Evangelista, M; Fairlie, WD; Gunasingh, G; Haass, NK; Harris, TJ; Herold, MJ; Hobbs, C; John, T; Lee, EF; Mariadason, JM; Ramnac, C; Rohrbeck, L; Segal, D; Strasser, A; Tran, S; Zhu, H | 1 |
Gilmore, A; King, L | 1 |
Ammatuna, E; de Jong, MRW; Langendonk, M; Nijland, M; Reitsma, B; van den Berg, A; van Meerten, T; Visser, L | 1 |
2 review(s) available for thiophenes and navitoclax
Article | Year |
---|---|
Targeting Mcl-1 and other Bcl-2 family member proteins in cancer therapy.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Drug Combinations; Drug Therapy, Combination; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Protein Isoforms; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Sulfonamides; Thiophenes | 2019 |
Emerging approaches to target mitochondrial apoptosis in cancer cells.
Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bridged Bicyclo Compounds, Heterocyclic; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Sulfonamides; Thiophenes | 2019 |
2 other study(ies) available for thiophenes and navitoclax
Article | Year |
---|---|
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival.
Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; bcl-X Protein; Bortezomib; Cell Line, Tumor; Cell Survival; Humans; Melanoma; Myeloid Cell Leukemia Sequence 1 Protein; Pyrimidines; Sulfonamides; Thiophenes | 2019 |
Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma.
Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bcl-2-Like Protein 11; bcl-X Protein; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Myeloid Cell Leukemia Sequence 1 Protein; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Rituximab; Signal Transduction; Sulfonamides; Thiophenes; Treatment Outcome; Vincristine | 2019 |